Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: The regulatory role of perivascular adipose tissue

Diabetes

Volumn 64, Issue 6, 2015, Pages 2207-2219

  Antonopoulos, Alexios S ^a   Margaritis, Marios ^a   Coutinho, Patricia ^a   Shirodaria, Cheerag ^a   Psarros, Costas ^b   Herdman, Laura ^a   Sanna, Fabio ^a   De Silva, Ravi ^c   Petrou, Mario ^c   Sayeed, Rana ^c   Krasopoulos, George ^c   Lee, Regent ^a   Digby, Janet ^a   Reilly, Svetlana ^a   Bakogiannis, Constantinos ^b   Tousoulis, Dimitris ^b   Kessler, Benedikt ^d   Casadei, Barbara ^a   Channon, Keith M ^a   Antoniades, Charalambos ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLINOSITOL 3 KINASE; RAC1 PROTEIN; RECOMBINANT PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ADIPOSE TISSUE; AGED; ARTERY WALL; ARTICLE; CORONARY ARTERY BYPASS SURGERY; DOWN REGULATION; DRUG TARGETING; EX VIVO STUDY; FEMALE; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; HYPOADIPONECTINEMIA; INTERNAL MAMMARY ARTERY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VERY ELDERLY; ARTERY; GENOTYPE; METABOLISM; MIDDLE AGED; REAL TIME POLYMERASE CHAIN REACTION;

ADIPONECTIN; ADIPOSE TISSUE; AGED; ARTERIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84937488978     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db14-1011     Document Type: Article

References (36)

1. Morawietz H. Endothelial NADPH oxidases: friends or foes? Basic Res Cardiol 2011; 106:521-525
2. Guzik TJ, West NE, Black E, et al. Vascular superoxide production by NAD(P) H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86:E85-E90
3. Muller G, Morawietz H. Nitric oxide, NAD(P) H oxidase, and atherosclerosis. Antioxid Redox Signal 2009; 11:1711-1731
4. Muller G, Morawietz H. NAD(P) H oxidase and endothelial dysfunction. Horm Metab Res 2009; 41:152-158
5. Guzik TJ, Harrison DG. Vascular NADPH oxidases as drug targets for novel antioxidant strategies. Drug Discov Today 2006; 11:524-533
6. Antoniades C, Bakogiannis C, Tousoulis D, et al. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 2010; 122(Suppl.):S66-S73
7. Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Adiponectin: from obesity to cardiovascular disease. Obes Rev 2009; 10:269-279
8. Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008; 29:2959-2971
9. Gao H, Fall T, van Dam RM, et al. Evidence of a causal relationship between adiponectin levels and insulin sensitivity: a Mendelian randomization study. Diabetes 2013; 62:1338-1344
10. Yaghootkar H, Lamina C, Scott RA, et al; GENESIS Consortium; RISC Consortium. Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes. Diabetes 2013; 62:3589-3598
11. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006; 48:1369-1377
12. Schnabel R, Messow CM, Lubos E, et al. Association of adiponectin with adverse outcome in coronary artery disease patients: results from the AtheroGene study. Eur Heart J 2008; 29:649-657
13. Feldman AM, Mann DL, She L, et al. Prognostic significance of biomarkers in predicting outcome in patients with coronary artery disease and left ventricular dysfunction: results of the biomarker substudy of the Surgical Treatment for Ischemic Heart Failure trials. Circ Heart Fail 2013; 6:461-472
14. Aghamohammadzadeh R, Greenstein AS, Yadav R, et al. Effects of bariatric surgery on human small artery function: evidence for reduction in perivascular adipocyte inflammation, and the restoration of normal anticontractile activity despite persistent obesity. J Am Coll Cardiol 2013; 62:128-135
15. Margaritis M, Antonopoulos AS, Digby J, et al. Interactions between vascular wall and perivascular adipose tissue reveal novel roles for adiponectin in the regulation of endothelial nitric oxide synthase function in human vessels. Circulation 2013; 127:2209-2221
16. Meijer RI, Bakker W, Alta CL, et al. Perivascular adipose tissue control of insulin-induced vasoreactivity in muscle is impaired in db/db mice. Diabetes 2013; 62:590-598
17. Wasowicz W, Nève J, Peretz A. Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin Chem 1993; 39:2522-2526
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
19. Breitfeld J, Stumvoll M, Kovacs P. Genetics of adiponectin. Biochimie 2012; 94:2157-2163
20. Antoniades C, Bakogiannis C, Leeson P, et al. Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. Circulation 2011; 124:335-345
21. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010; 208:412-420
22. Richards JB, Waterworth D, O'Rahilly S, et al; GIANT Consortium. A genome-wide association study reveals variants in ARL15 that influence adiponectin levels. PLoS Genet 2009; 5:e1000768
23. Judkins CP, Sobey CG, Dang TT, Miller AA, Dusting GJ, Drummond GR. NADPH-induced contractions of mouse aorta do not involve NADPH oxidase: a role for P2X receptors. J Pharmacol Exp Ther 2006; 317:644-650
24. Violi F, Pignatelli P. Clinical application of NOX activity and other oxidative biomarkers in cardiovascular disease: a critical review. Antioxid Redox Signal. 24 February 2014 [Epub ahead of print]
25. Konior A, Schramm A, Czesnikiewicz-Guzik M, Guzik TJ. NADPH oxidases in vascular pathology. Antioxid Redox Signal 2014; 20:2794-2814
26. Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P) H oxidase and endothelial nitric oxide synthase. Circulation 2002; 105:1656-1662
27. Lee R, Margaritis M, Channon KM, Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 2012; 19:2504-2520
28. Paneni F, Beckman JA, Creager MA, Cosentino F. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur Heart J 2013; 34:2436-2443
29. Taye A, Saad AH, Kumar AH, Morawietz H. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose. Eur J Pharmacol 2010; 627:42-48
30. Guzik TJ, Sadowski J, Kapelak B, et al. Systemic regulation of vascular NAD(P) H oxidase activity and nox isoform expression in human arteries and veins. Arterioscler Thromb Vasc Biol 2004; 24:1614-1620
31. Greenstein AS, Khavandi K, Withers SB, et al. Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients. Circulation 2009; 119:1661-1670
32. Angelico F, Loffredo L, Pignatelli P, et al. Weight loss is associated with improved endothelial dysfunction via NOX2-generated oxidative stress down-regulation in patients with the metabolic syndrome. Intern Emerg Med 2012; 7: 219-227
33. Cosentino F, Patton S, d'Uscio LV, et al. Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J Clin Invest 1998; 101: 1530-1537
34. Kwon T, Kwon DY, Chun J, Kim JH, Kang SS. Akt protein kinase inhibits Rac1-GTP binding through phosphorylation at serine 71 of Rac1. J Biol Chem 2000; 275:423-428
35. Fujishima Y, Maeda N, Matsuda K, et al. Effect of adiponectin on cardiac β-catenin signaling pathway under angiotensin II infusion. Biochem Biophys Res Commun 2014; 444:224-229
36. Lin HV, Kim JY, Pocai A, et al. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes 2007; 56: 1969-1976